Background Respiratory tract infections with Pseudomonas aeruginosa occur in most
people with cystic fibrosis (CF). Established chronic P aeruginosa infection is virtually …

Progressive obstructive lung disease secondary to chronic airway infection, coupled with
impaired host immunity, is the leading cause of morbidity and mortality in cystic fibrosis (CF) …

Background The active involvement of patients and the public in the design and delivery of
health research has been increasingly encouraged, if not enforced. Knowledge of how this …

Pseudomonas aeruginosa is a Gram-negative opportunistic pathogen that causes high
morbidity and mortality in cystic fibrosis (CF) and immunocompromised patients, including …

This is the third in a series of four papers updating the European Cystic Fibrosis Society
(ECFS) standards for the care of people with CF. This paper focuses on recognising and …

The role of neutrophils in host defense involves several cell processes including
phagocytosis, degranulation of antimicrobial proteins, and the release of neutrophil …

Introduction: Aerosolised drugs have been approved for several diseases such as cystic
fibrosis and diabetes. Moreover; there are already drugs for pulmonary hypertension in …

The airway mucus of patients with cystic fibrosis has altered properties, which create a
microenvironment primed for chronic infections that are difficult to treat. These complex …

This is the third in a series of four papers updating the European Cystic Fibrosis Society
(ECFS) standards for the care of people with CF. This paper focuses on recognising and …

Medical Sciences Forum | Free Full-Text | Research on Antimicrobial Utilization and Resistance
in England 2021–22 (ESPAUR Report) Next Article in Journal National Antimicrobial …